{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/2070891383",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1044091662"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#2070891383",
  "code": "EH76.0",
  "source": "http://id.who.int/icd/entity/2070891383",
  "classKind": "category",
  "foundationChildElsewhere": [
    {
      "label": {
        "@language": "en",
        "@value": "Oral mucositis due to cancer chemotherapy"
      },
      "foundationReference": "http://id.who.int/icd/entity/1370112759",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/1634507618"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Neutrophilic eccrine hidradenitis"
      },
      "foundationReference": "http://id.who.int/icd/entity/789957175",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/440403304/other"
    }
  ],
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/2070891383/postcoordinationScale/associatedWith",
      "axisName": "http://id.who.int/icd/schema/associatedWith",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/1583926619",
        "http://id.who.int/icd/release/11/2024-01/mms/1323892810"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Dermatoses resulting from cytotoxic or cancer chemotherapy"
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Dermatoses resulting from cytotoxic or cancer chemotherapy"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Cytotoxic chemotherapy-induced recall reaction"
      },
      "foundationReference": "http://id.who.int/icd/entity/571134141"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Drug-related adverse cutaneous reactions to epidermal growth factor receptor inhibitor therapy"
      },
      "foundationReference": "http://id.who.int/icd/entity/2029825632"
    },
    {
      "label": {
        "@language": "en",
        "@value": "EGF receptor inhibitor-related papulopustular drug eruption"
      },
      "foundationReference": "http://id.who.int/icd/entity/2029825632"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Eccrine syringosquamous metaplasia"
      },
      "foundationReference": "http://id.who.int/icd/entity/407987403"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Palmoplantar erythrodysaesthesia due to cytotoxic chemotherapy"
      },
      "foundationReference": "http://id.who.int/icd/entity/593924589"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Acral erythema due to cytotoxic chemotherapy"
      },
      "foundationReference": "http://id.who.int/icd/entity/593924589"
    }
  ]
}